EPOS2020/EUFOREA Expert Consensus Defines Disease States and Therapeutic Goals in CRSwNP

Severe chronic rhinosinusitis with nasal polyps or CRSwNP is a debilitating disease which has a significant impact on a patient's quality of life. It is present in about 1-2% of the European population and it can be incredibly debilitating. As our understanding of the condition evolves and new treatment options become available definitions related to CRSwNP must be constantly reviewed. With this in mind, a consensus meeting was held in June 2023 which brought together the expert panel members of EPOS2020 and EUFOREA. It sought to redefine several crucial definitions related to CRSwNP including control, remission, cure, remodelling, disease progression and modification.

Click here to read the open access paper

In this show, we will discuss the work undertaken by EUFOREA and EPOS expert members in the quest to improve definitions, communication and treatment outcomes. Joining us is Prof. Valerie Lund, Professor Emeritus of Rhinology at the Ear Institute, University College London. She is also an Honorary Consultant ENT Surgeon at the Royal National Throat Nose and Ear Hospital at University College Hospital in London, and Prof. Amber Luong, Professor and Surgeon-Scientist in the Dept of Otorhinolaryngology and Institute of Molecular Medicine in Houston, Texas, United States